scispace - formally typeset
J

Josephine Nalbantoglu

Researcher at Montreal Neurological Institute and Hospital

Publications -  99
Citations -  5257

Josephine Nalbantoglu is an academic researcher from Montreal Neurological Institute and Hospital. The author has contributed to research in topics: Duchenne muscular dystrophy & Dystrophin. The author has an hindex of 39, co-authored 99 publications receiving 5090 citations. Previous affiliations of Josephine Nalbantoglu include University of Western Ontario & McGill University.

Papers
More filters
Journal ArticleDOI

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

TL;DR: The concept that apoE4 plays a crucial role in the cholinergic dysfunction associated with AD and may be a prognostic indicator of poor response to therapy with acetylcholinesterase inhibitors in AD patients is strongly supported.
Journal ArticleDOI

Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein

TL;DR: Transgenic mice expressing the amyloidogenic carboxy-terminal 104 amino acids of APP develop, with ageing, extracellular β-amyloid immunoreactivity, increased gliosis and microglial reactivity, as well as cell loss hi the CA1 region of the hippocampus, indicating that alterations in the processing of APP may have considerable physiological effects on synaptic plasticity.
Journal ArticleDOI

High Threshold for Induction of the Stress Response in Motor Neurons Is Associated with Failure to Activate HSF1

TL;DR: The results indicate that the high threshold for induction of the stress response in motor neurons stems from an impaired ability to activate the main heat shock–stress sensor, HSF1.
Journal ArticleDOI

IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth In vivo

TL;DR: An essential role for IRE1-dependent signaling pathways in response to ischemia is suggested and this protein is identified as a potential therapeutic target to control both the angiogenic switch and tumor development.
Journal ArticleDOI

Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism

TL;DR: High performance liquid chromatographic analyses of incubations of β-amyloid with neutral endopeptidase revealed at least nine product peaks, indicating that neutral endopesidedase can cleave β- amyloid at multiple sites.